Cargando…
Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice
The treatment of patients with advanced breast cancer has developed further in recent years. In addition to therapeutic progress in the established subgroups (hormone receptor and HER2 status), there are now therapies which are geared to individual molecular characteristics, such as PARP inhibitor t...
Autores principales: | Janni, Wolfgang, Schneeweiss, Andreas, Müller, Volkmar, Wöckel, Achim, Lux, Michael P., Hartkopf, Andreas D., Nabieva, Naiba, Taran, Florin-Andrei, Tesch, Hans, Overkamp, Friedrich, Lüftner, Diana, Belleville, Erik, Schütz, Florian, Fasching, Peter A., Fehm, Tanja N., Kolberg, Hans-Christian, Ettl, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414305/ https://www.ncbi.nlm.nih.gov/pubmed/30880825 http://dx.doi.org/10.1055/a-0842-6661 |
Ejemplares similares
-
Update Breast Cancer 2019 Part 1 – Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer
por: Hartkopf, Andreas D., et al.
Publicado: (2019) -
Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer
por: Welslau, Manfred, et al.
Publicado: (2019) -
Update Breast Cancer 2018 (Part 4) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer
por: Müller, Volkmar, et al.
Publicado: (2018) -
Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer
por: Wöckel, Achim, et al.
Publicado: (2018) -
Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers
por: Taran, Florin-Andrei, et al.
Publicado: (2018)